生物科技公司的每股收益超过第一季度的预期,每股收益为0.30美元,收入为7449万美元. BioStem Technologies exceeded Q1 earnings estimates with EPS of 0.30 and revenue of $74.49M.

BioStem Technologies(BSEM)报告了Q1收入,超过了预期,EPS的估计数为0.30对0.12,收入为74.49M对43.99M。 BioStem Technologies (BSEM) reported Q1 earnings, exceeding expectations with EPS of 0.30 vs. 0.12 estimate and revenue of $74.49M vs. $43.99M estimate. 公告发布后，股价上涨0.50美元至12.50美元，成交量为65,600股，而平均成交量为25,206股。 Following the announcement, shares increased by 0.50 to $12.50 on a volume of 65,600 shares, compared to the average of 25,206. 生命科学公司侧重于制药和再生医药产品和服务。 The life sciences company focuses on pharmaceutical and regenerative medicine products and services.